ctSearch Results
Original Query
AIDS - What is Conference Retroviruses
Search Results
- aids conference retroviruses
(ritonavir)-boosted Reyataz (atazanavir) is more likely to contribute to bone loss than Sustiva (efavirenz), according to new data from the AIDS Clinical Trials Group (ACTG) reported Thursday, February 18, at the 17th Conference on Retroviruses and Opportunistic Infections in San Francisco
residents of Washington, DC, are being tested and diagnosed earlier, entering into care faster and progressing to AIDS more slowly in recent years, according to data presented Wednesday, February 17, at the 17th Conference on Retroviruses and Opportunistic Infections (CROI)
either Epzicom (abacavir plus lamivudine) or Truvada (tenofovir plus emtricitabine), according to final results from a federally funded AIDS Clinical Trials Group (ACTG) study reported on Wednesday, February 17, at the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco
Preview
For more information on each topic click the link(s) above.
Contact
Web : http://c-t-search.infoE-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo

No comments:
Post a Comment